Exploring the Biology, Virulence, and General Aspects of Candida dubliniensis
- PMID: 39722735
- PMCID: PMC11669290
- DOI: 10.2147/IDR.S497862
Exploring the Biology, Virulence, and General Aspects of Candida dubliniensis
Abstract
Fungal infections have become a growing public health concern, aggravated by the emergence of new pathogenic species and increasing resistance to antifungal drugs. The most common candidiasis is caused by Candida albicans; however, Candida dubliniensis has become an emerging opportunistic pathogen, and although less prevalent, it can cause superficial and systemic infections, especially in immunocompromised individuals. This yeast can colonize the oral cavity, skin, and other tissues, and has been associated with oral infections in patients with human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS), making it difficult to treat. The special interest in the study of this species lies in its ability to evade commonly used antifungal drugs, such as fluconazole, under different concentrations. In addition, it is difficult to identify because it can be confused with the species C. albicans, which could interfere with adequate treatment. Although the study of virulence factors in C. dubliniensis is limited, proteomic comparisons with C. albicans indicate that these virulence factors could be similar between the two species. However, differences could exist considering the evolutionary processes and lifestyle of each species. In this study, a detailed review of the current literature on C. dubliniensis was conducted, considering aspects such as biology, possible virulence factors, immune response, pathogen-host interaction, diagnosis, and treatment.
Keywords: candidiasis; emerging pathogens; host–fungus interaction; non-albicans species; virulence factors.
© 2024 Gómez-Gaviria et al.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures


Similar articles
-
Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans.FEMS Yeast Res. 2004 Jan;4(4-5):369-76. doi: 10.1016/S1567-1356(03)00240-X. FEMS Yeast Res. 2004. PMID: 14734017 Review.
-
Candida dubliniensis, a new fungal pathogen.J Basic Microbiol. 2002;42(3):207-27. doi: 10.1002/1521-4028(200206)42:3<207::AID-JOBM207>3.0.CO;2-C. J Basic Microbiol. 2002. PMID: 12111748 Review.
-
The Emerging Pathogen Candida metapsilosis: Biological Aspects, Virulence Factors, Diagnosis, and Treatment.Infect Drug Resist. 2024 Jan 20;17:171-185. doi: 10.2147/IDR.S448213. eCollection 2024. Infect Drug Resist. 2024. PMID: 38268929 Free PMC article. Review.
-
Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole.J Clin Microbiol. 2002 Sep;40(9):3135-9. doi: 10.1128/JCM.40.9.3135-3139.2002. J Clin Microbiol. 2002. PMID: 12202543 Free PMC article.
-
The role of Candida dubliniensis in oral candidiasis in human immunodeficiency virus-infected individuals.Crit Rev Microbiol. 2000;26(1):59-68. doi: 10.1080/10408410091154183. Crit Rev Microbiol. 2000. PMID: 10782340 Review.
References
Publication types
LinkOut - more resources
Full Text Sources